Reuters logo
in 2 months
BRIEF-Syros announces first patient dosed in phase 1 clinical trial of SY-1365
May 15, 2017 / 12:22 PM / in 2 months

BRIEF-Syros announces first patient dosed in phase 1 clinical trial of SY-1365

1 Min Read

May 15 (Reuters) - Syros Pharmaceuticals Inc

* Syros announces first patient dosed in phase 1 clinical trial of SY-1365, its first-in-class selective CDK7 inhibitor, in patients with advanced solid tumors Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below